You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

unknown primary cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus

Recruiting
  • Cancer of Unknown Primary Site
  • +2 more
  • Transoral Ultrasound
  • Copenhagen, Denmark
  • +1 more
May 2, 2023

Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 18, 2023

Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

Recruiting
  • Unknown Primary Tumors
  • Oropharynx Cancer
  • Detection of lesions using fluorescence molecular imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 20, 2023

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

    Recruiting
    • Cancer of Unknown Primary Site
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Carcinoma of Unknown Primary: A Comparison Across Tissue and

    Recruiting
    • Cancer of Unknown Primary Site
      • Bath, United Kingdom
      • +6 more
      Oct 18, 2022

      Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

      Recruiting
      • Breast Cancer
      • +10 more
        • Hamilton, Ontario, Canada
        • +6 more
        Apr 21, 2022

        Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)

        Not yet recruiting
        • Cancer of Unknown Primary Site
        • Bendigo, Victoria, Australia
        • +2 more
        Feb 28, 2022

        Cancer of Unknown Primary Site Trial in Shanghai (tissue-of-origin (ORIGIN-PanCA?R) profiling)

        Completed
        • Cancer of Unknown Primary Site
        • tissue-of-origin (ORIGIN-PanCA○R) profiling
        • Shanghai, China
          Fudan University Cancer Hospital
        Jan 21, 2022

        Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

        Recruiting
        • Neuroendocrine Tumors
        • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Jan 19, 2023

        Integrated Molecular Profiling in Advanced Cancers Trial

        Active, not recruiting
        • Breast Cancer
        • +9 more
          • Toronto, Ontario, Canada
            Princess Margaret Hospital
          Sep 26, 2022

          Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

          Recruiting
          • Cancer of Unknown Primary
          • +5 more
          • Tislelizumab plus chemotherapy
          • Shanghai, Shanghai, China
            ChangZheng Hospital
          Feb 6, 2022

          Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

          Recruiting
          • Carcinoma of Unknown Primary
          • Pembrolizumab Injection
          • Calgary, Alberta, Canada
          • +2 more
          Feb 18, 2022

          Circulating Biomarkers in Oropharyngeal Cancers

          Active, not recruiting
          • Oropharynx Squamous Cell Carcinoma
          • +3 more
            • Orebro, Sweden
              Anna Oldaeus Almerén
            Jun 13, 2023

            Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

            Active, not recruiting
            • Analgesia
            • +6 more
            • Copenhagen, Denmark
              Department of Otorhinolaryngology, Head and Neck Surgery & Audio
            Oct 14, 2022

            Cancer of Unknown Primary Trial in Shanghai (Recombinant humanized anti-PD-1 mAb injection)

            Recruiting
            • Cancer of Unknown Primary
            • Recombinant humanized anti-PD-1 monoclonal antibody injection
            • Shanghai, China
              Fudan University Shanghai Cancer Center
            Apr 18, 2022

            First-line Treatment Among Cancer of Unknown Primary in China

            Recruiting
            • Cancer of Unknown Primary Site
            • no intervention
            • Shanghai, Shanghai, China
              Fudan University Shanghai Cencer Center
            Jul 6, 2021

            Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

            Recruiting
            • Non Small Cell Lung Cancer
            • +6 more
            • Fairfax, Virginia
              NEXT Oncology
            Jun 7, 2023

            Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

            Recruiting
            • Malignant Digestive System Neoplasm
            • +12 more
            • Computed Tomography
            • +4 more
            • Houston, Texas
              M D Anderson Cancer Center
            Sep 22, 2022

            Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site Trial in Cambridge (FoundationOne CDx and FoundationOne Liquid

            Recruiting
            • Rare Cancers
            • +2 more
            • FoundationOne CDx and FoundationOne Liquid CDx
            • Cambridge, Massachusetts
              TargetCancer Foundation
            Oct 13, 2021

            Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency Trial in Australia (APL-501)

            Completed
            • Solid Tumor
            • +3 more
            • Camperdown, New South Wales, Australia
            • +4 more
            May 5, 2022

            Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

            Recruiting
            • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
            • +5 more
            • Medical Chart Review
            • +3 more
            • Scottsdale, Arizona
            • +1 more
            Mar 15, 2022

            Positron Emission Tomography in Detecting Primary Tumor in Cases

            Recruiting
            • Metastasis of Unknown Origin
            • PET/CT
            • Sohag, Egypt
              Sohag university Hospital
            Oct 11, 2023

            Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the

            Recruiting
            • Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
            • +2 more
            • Atezolizumab
            • +2 more
            • Sacramento, California
              University of California Davis Comprehensive Cancer Center
            Jan 19, 2022

            Breast Carcinoma, Carcinoma of Unknown Primary, CNS Carcinoma Trial in Scottsdale, Jacksonville (Biospecimen Collection, Genetic

            Recruiting
            • Breast Carcinoma
            • +10 more
            • Biospecimen Collection
            • Genetic Testing
            • Scottsdale, Arizona
            • +1 more
            Jul 15, 2022